Cargando…
Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel MBTPS2 variant in Osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a heritable and chronically debilitating skeletal dysplasia. Patients with OI typically present with reduced bone mass, tendency for recurrent fractures, short stature and bowing deformities of the long bones. Mutations causative of OI have been identified in over 20...
Autores principales: | Lim, Pei Jin, Marcionelli, Giulio, Srikanthan, Pakeerathan, Ndarugendamwo, Timothée, Pinner, Jason, Rohrbach, Marianne, Giunta, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248412/ https://www.ncbi.nlm.nih.gov/pubmed/37305034 http://dx.doi.org/10.3389/fendo.2023.1195704 |
Ejemplares similares
-
Omics Profiling of S2P Mutant Fibroblasts as a Mean to Unravel the Pathomechanism and Molecular Signatures of X-Linked MBTPS2 Osteogenesis Imperfecta
por: Lim, Pei Jin, et al.
Publicado: (2021) -
MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta
por: Lindert, Uschi, et al.
Publicado: (2016) -
Management of Osteogenesis Imperfecta
por: Ralston, Stuart H., et al.
Publicado: (2020) -
Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta
por: Lindert, Uschi, et al.
Publicado: (2015) -
NGS analysis of collagen type I genes in Polish patients with Osteogenesis imperfecta: a nationwide multicenter study
por: Sałacińska, Kinga, et al.
Publicado: (2023)